Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Billionaire Singer Lifts Stake in Cabelas Inc. (CAB), Deerfield Bets on Beloranib, Plus Two Other Moves

Numerous closely-watched hedge fund vehicles are currently disclosing their equity positions as of the end of 2015, so individual investors can monitor what moves hedge fund managers made during the fourth quarter by examining the deluge of 13Fs currently pouring in. Nevertheless, investors tend to use various investment strategies, so some investors might not find these filings handy, as they are more useful for long term-oriented investors. But there is another way through which individual investors can monitor hedge fund moves. Other SEC filings, such as 13D, 13G, and Form 4 filings tend to reveal up-to-date moves made by renowned investment firms, and could be used to mimic hedge funds’ moves with a lag of mere days. Having said that, this article will digest four such filings submitted by widely-known managers Paul Singer, James E. Flynn, and others.

At Insider Monkey, we track around 730 hedge funds and institutional investors. Through extensive backtests, we have determined that imitating some of the stocks that these investors are collectively bullish on can help retail investors generate double digits of alpha per year. The key is to focus on the small-cap picks of these funds, which are usually less followed by the broader market and allow for larger price inefficiencies (see more details about our small-cap strategy).

Let’s kick off our discussion by analyzing the amended 13D filing submitted by Daniel LewisOrange Capital LLC, which reveals an ownership stake of 30.83 million shares of Bellatrix Exploration Ltd (NYSE:BXE). This denotes a decrease of 1.90 million shares from the stake revealed through the fund’s 13F filing for the September quarter. The 30.83 million-share stake accounts for 16.1% of the company’s outstanding common stock. Most importantly, Daniel Lewis resigned from the company’s Board of Directors as of February 10, 2016.

The shares of the Canadian-based, growth-oriented oil and gas company are down by 66% over the past 12-month period. Earlier this month, Moody’s Investors Services completed a review of six Canadian and two U.S. exploration and production companies, including Bellatrix Exploration Ltd (NYSE:BXE). As a result, Moody’s downgraded the company’s Corporate Family Rating to Caa1 from B1, citing “material decline in Bellatrix’s cash flow expected in 2016 and 2017”.  The sustained decline in oil prices is anticipated to weaken the company’s cash flows, so the Canadian E&P company will most likely “be tight on its sole financial covenant in 2016”, which will limit “its ability to draw under the revolver”. Despite that, Bellatrix plans to focus on its Spirit River natural gas play, which is among the lowest supply cost natural gas plays in North America. Jim Simons’ Renaissance Technologies LLC acquired a new stake of 253,000 shares in Bellatrix Exploration Ltd (NYSE:BXE) during the fourth quarter.

Daniel Lewis
Daniel Lewis
Orange Capital

The next two pages of this article will discuss three other filings recently submitted with the SEC.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.